4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease

被引:62
作者
Drake, J
Petroze, R
Castegna, A
Ding, QX
Keller, JN
Markesbery, WR
Lovell, MA
Butterfield, DA [1 ]
机构
[1] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA
[2] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40506 USA
[3] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
[4] Univ Kentucky, Ctr Membrane Sci, Lexington, KY 40506 USA
关键词
Alzheimer's disease; DNA oxidation; histone-DNA interactions; spin labeling; protein conformation;
D O I
10.1016/j.neulet.2003.11.047
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is increasing evidence of DNA oxidation and altered DNA repair mechanisms in Alzheimer's disease (AD) brain. Histones, which interact with DNA, conceivably could provide a protective shield for DNA against oxidative stress. However, because of their abundant lysine residues, histones may be a target for 4-hydroxynonenal (HNE) modification. In this study, we have shown that HNE binds to histones and that this binding affects the conformation of the histone, measured by electron paramagnetic resonance in conjunction with a protein-specific spin label. The covalent modification to the histone by HNE affects the ability of the histone to bind DNA. Interestingly, acetylated histones, appear to be more susceptible to HNE modifications than control histones. Conceivably, altered DNA-histone interactions, subsequent to oxidative modification of histones by the lipid peroxidation product HNE, may contribute to the vulnerability of DNA to oxidation in AD brain. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 21 条
[1]   Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells [J].
Bohr, VA .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (09) :804-812
[2]   Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide [J].
Butterfield, DA ;
Drake, J ;
Pocernich, C ;
Castegna, A .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (12) :548-554
[3]   Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration [J].
Butterfield, DA ;
Boyd-Kimball, D ;
Castegna, A .
JOURNAL OF NEUROCHEMISTRY, 2003, 86 (06) :1313-1327
[4]   Lipid peroxidation and protein oxidation in Alzheimer's disease brain:: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress [J].
Butterfield, DA ;
Lauderback, CM .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (11) :1050-1060
[5]  
BUTTERFIELD DA, 1982, BIOL MAGN RESON, V4, P1
[6]   Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease [J].
de la Monte, SM ;
Luong, T ;
Neely, TR ;
Robinson, D ;
Wands, JR .
LABORATORY INVESTIGATION, 2000, 80 (08) :1323-1335
[7]   CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES [J].
ESTERBAUER, H ;
SCHAUR, RJ ;
ZOLLNER, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) :81-128
[8]   Increased nuclear DNA oxidation in the brain in Alzheimer's disease [J].
Gabbita, SP ;
Lovell, MA ;
Markesbery, WR .
JOURNAL OF NEUROCHEMISTRY, 1998, 71 (05) :2034-2040
[9]   Structure and function of the core histone N-termini: more than meets the eye [J].
Hansen, JC ;
Tse, C ;
Wolffe, AP .
BIOCHEMISTRY, 1998, 37 (51) :17637-17641
[10]   The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain:: the role of Aβ1-42 [J].
Lauderback, CM ;
Hackett, JM ;
Huang, FF ;
Keller, JN ;
Szweda, LI ;
Markesbery, WR ;
Butterfield, DA .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (02) :413-416